Irritable Bowel Disease Flashcards
(52 cards)
What is ulcerative colitis
Mucosal inflammation confined to the rectum and colon with superficial ulcerations
Infllammation limited to the rectum
Procritis
What is Crohn’s disease
Deep transmural inflammation of any part of the GIT → diarrrhea
Difference between CD and UC
GD: entire GIT, transmural, non-continuous (cobblestone)
UC: Colon (rectum), superficial, continuous
How to diagnosis IBD
Colonoscopy with tissue biopsy
Endoscopy if upper GI sx are present
Lifestyle mods for IBD
Smaller, more frequent meals → low fat and dairy
Antidiarrheals or antispasmodics for sx (Dicyclomine)
Vitamin supplements due to malabsorption
Probiotics (Lactobacillus, Bifidobacterium) → reduce abdominal pain
Best treatment for acute exacerbations
Short courses of PO or IV steroids
Tx for mild CD
PO budesonide ≤3 months → dc to thiopurine or methotrexate
Taper steroid over 8-12 weeks
Tx for mod-severe CD
Anti-TNF +/- methotrexate or thiopurine
IL receptor antagonist
Integrin receptor antagonist
Tx for refractory CD
JAK inhibitor
Integrin receptor antagonist
Tx for mild UC
Mesalamine:
Rectal → distal disease
Rectal +/- PO → extensive disease
Tx for moderate-severe UC
Anti-TNF +/- thiopurine
IL recepor antagonist
Integrin receptor antagonist
Tx for refractory UC
JAK inhibitor
PO Sphingosine-1-phosphate receptor modulators
PO steroids for CD
Prednione
Budesonide
Budesonide
Enterocort EC (CD)
Uceris (UC)
Short term ADR of PO steroids
Weight gain, ↑ appetite, emotional instability, insomnia
Long term ADR of PO steroids
Hyperglycemia, Cushings/adrenal suppression, osteoporosis, impaired wound healing, ↑ BP
Taper cut off for steroids
≥2 weeks
What to consider if long term steroids are require
Assess bone density → optimize calcium and Vit D intake → bisphosphonates may be required
Why is budesonide the steroid of choice for IBD
Undergoes extensive first-pass metabolism to reduce systemic exposure
Indication for rectal steroids
UC only (distal)
Rectal steroids
Hydrocortisone (enema, foam)
Budesonide (foam)
Metabolism of budesonide
CYP3A4
MOA and indication for mesalamine
Aminosalicylates to treat UC → topical anti-inflammatory effect in the GIT